Covestor’s Pacira BioSciences PCRX Stock Holding History

Covestor’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10K	Buy	449 +62	+16%	+$1.38K	0.01%	1416
2025 Q4	$10K	Buy	387 +5	+1%	+$119	0.01%	1589
2025 Q3	$10K	Sell	382 -39	-9%	-$958	0.01%	1605
2025 Q2	$10K	Buy	421 +157	+59%	+$3.96K	0.01%	1607
2025 Q1	$6K	Buy	264 +259	+5,180%	+$6.2K	﹤0.01%	1711
2024 Q4	$0	Sell	5 -103	-95%	-$1.81K	﹤0.01%	2615
2024 Q3	$2K	Buy	108 +47	+77%	+$804	﹤0.01%	1844
2024 Q2	$2K	Buy	61 +41	+205%	+$1.17K	﹤0.01%	1876
2024 Q1	$1K	Buy	20 +17	+567%	+$522	﹤0.01%	2064
2023 Q4	$0	Hold	3	–	–	﹤0.01%	2584
2023 Q3	$0	Sell	3 -1	-25%	-$36	﹤0.01%	2573
2023 Q2	$0	Sell	4 -43	-91%	-$1.78K	﹤0.01%	2523
2023 Q1	$2K	Buy	47 +43	+1,075%	+$1.71K	﹤0.01%	1778
2022 Q4	$0	Hold	4	–	–	﹤0.01%	2473
2022 Q3	$0	Sell	4 -2	-33%	-$111	﹤0.01%	2432
2022 Q2	$0	Sell	6 -43	-88%	-$2.82K	﹤0.01%	2251
2022 Q1	$4K	Sell	49 -21	-30%	-$1.4K	﹤0.01%	1549
2021 Q4	$4K	Buy	+70	New	+$3.86K	0.01%	1409

Other funds holding PCRX

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return